Biofrontera Inc. Common Stock

BFRINASDAQUSD
1.46 USD
0.02 (1.35%)AT CLOSE (11:59 AM EDT)
1.47
0.01 (0.34%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
1.47
0.01 (0.34%)
🔴Market: CLOSED

BFRI is currently priced at $1.45. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 24, 2026.

Open?$1.48
High?$1.55
Low?$1.41
Prev. Close?$1.48
Volume?995.0K
Avg. Volume?448.2K
VWAP?$1.48
Rel. Volume?2.22x
Bid / Ask
Bid?$1.22 × 100
Ask?$1.68 × 100
Spread?$0.46
Midpoint?$1.45
Valuation & Ratios
Market Cap?22.0M
Shares Out?14.9M
Float?11.3M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?3.69
EPS?-$0.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
22.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
0
Momentum?
50
Short Sent.?
60
Piotroski F-Score?5/9Mixed
Altman Z-Score?-5.91Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.54%Low
Short Interest?61.1K
Days to Cover?1.0
Free Float11.3M
Avg Daily Volume359.8K
Settlement Date2026-07-31
Financial Health
Current Ratio?1.18Adequate
Quick Ratio?1.08Adequate
Cash Ratio?0.44Low
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A
P/B?
Peers
100
S&P
47
3.69FAIR
P/S?
Peers
100
S&P
97
0.48CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.5CHEAP
EV/Sales?
Peers
100
S&P
97
0.48CHEAP
Returns & Efficiency
ROE?
S&P
3
-106.9%WEAK
ROA?
S&P
3
-26.5%WEAK
Cash Flow & Enterprise
FCF?$-7930000
Enterprise Value?$21.9M
Fundamentals ratios updated end of day